Today, it was reported that Chinese scientists have identified potential pathogenic targets within the structures of the SARS and avian influenza viruses. Medical experts emphasized that this breakthrough represents a significant global advancement, offering a solid foundation for the future development of drugs with independent intellectual property rights to combat these viruses.
The 5th Shanghai International Respiratory Symposium and the 16th Asia-Pacific Respiratory Therapy Association kicked off in Shanghai today. Over three days, the event brought together leading international scholars, including Dr. Raozi, an academician of the Chinese Academy of Sciences, and Dr. Bai Chunxue, vice chairman of the Chinese Medical Association’s Respiratory Branch. More than 50 global respiratory experts will deliver keynote speeches throughout the conference.
During the opening session, Dr. Raozi delivered a presentation titled “Progress in the Study of the Structure of SARS and Avian Influenza Viruses,†highlighting recent breakthroughs in the field. His speech impressed both Chinese and international attendees, who applauded enthusiastically. Dr. Raozi noted that while it's uncertain whether SARS will re-emerge, related diseases could still pose a threat, urging continued research into the virus.
Dr. Bai Chunxue, chairman of the conference and a respiratory specialist at Zhongshan Hospital, praised the new findings as a world-leading achievement with great significance for future drug development. He emphasized that the discovery offers valuable insights for creating innovative treatments with independent intellectual property.
In addition to discussing viral research, many experts at the conference reiterated the dangers of smoking. According to recent data, China has 350 million direct smokers and 450 million people exposed to secondhand smoke. Dr. Bai highlighted that smoking is a major risk factor for chronic obstructive pulmonary disease (COPD), lung cancer, and ischemic heart disease. He pointed out that approximately 1.28 million people die annually from COPD, which equates to two deaths every minute. By 2025, lung cancer is expected to claim one million lives each year in China. Currently, over two million people die yearly from smoking-related illnesses.
Dr. Bai also mentioned that the latest research presented at the conference goes beyond traditional smoking prevention strategies. The findings suggest that chronic respiratory diseases are closely linked to immune function, and early detection can significantly reduce mortality. He recommended that lung function tests be included in routine medical checkups for students and job applicants, especially among smokers, to improve early diagnosis and treatment outcomes.
Functional Beverages,Honey Sliced Red Ginseng,Herbal Supplements Ginseng Honey Slice,Red Ginseng Extract
Yanbian Dangun Pharmaceutical Co., Ltd. , https://www.tanjunpharmacy.com